Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 209-214

  Russell, Fraser D ^a   Kearns, Philip ^a   Toth, Istvan ^a   Molenaar, Peter ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CALCIUM ION; EDETIC ACID; FURIN; HORMONE PRECURSOR; TRYPSIN; UROTENSIN II;

ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPICARDIUM; FIBROBLAST CULTURE; HEART RIGHT ATRIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MASS SPECTROMETRY; MESOTHELIUM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; UMBILICAL VEIN;

CELLS, CULTURED; EPITHELIUM; FURIN; HUMANS; PROTEIN PRECURSORS; TRYPSIN; UROTENSINS;

EID: 3042682003     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.065425     Document Type: Article

References (27)

1. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature (Lond) 401:282-286.
2. Böhm F and Pernow J (2002) Urotensin II evokes potent vasoconstriction in humans in vivo. Br J Pharmacol 135:25-27.
3. Conlon JM, Arnold-Reed D, and Balment RJ (1990) Post-translational processing of prepro-urotensin II. FEBS Lett 266:37-40.
4. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, and Vaudry H (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95:15803-15808.
5. Douglas SA and Ohlstein EH (2000) Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 10:229-237.
6. Douglas SA, Tayara L, Ohlstein EH, Halawa N, and Giaid A (2002) Congestive heart failure and expression of myocardial urotensin II. Lancet 359:1990-1997.
7. Heller J, Schepke M, Neef M, Woitas RP, and Sauerbruch T (2001) Increased urotensin II plasma levels in patients with cirrhosis. J Hepatol 34 (Suppl 1):382.
8. Hunt PJ, Espiner EA, Nicholls MG, Richards AM, and Yandle TG (1997) The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to aminoterminal BNP and BNP-32. Peptides 18:1475-1481.
9. Le Moine O, Devaster JM, Deviere J, Thiry P, Cremer M, and Ooms HA (1994) Trypsin activity. A new marker of acute alcoholic pancreatitis. Dig Dis Sci 39: 2634-2638.
10. MacLean MR, Alexander D, Stirrat A, Gallagher M, Douglas SA, Ohlstein EH, Morecroft I, and Polland K (2000) Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. Br J Pharmacol 130:201-204.
11. Maguire JJ, Kuc RE, and Davenport AP (2000) Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131:441-446.
12. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, and Thomas G (1992) Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267:16396-16402.
13. Nakayama K (1997) Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327:625-635.
14. Neri Serneri GG, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, Janming X, Bertolozzi I, Boddi M, Lisi GF, et al. (2000) Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy. Endothelin-1 system in the human failing heart. Circ Res 86:377-385.
15. Ng LL, Loke I, O'Brien RJ, Squire IB, and Davies JE (2002) Plasma urotensin in human systolic heart failure. Circulation 106:2877-2880.
16. Richards AM, Nicholls MG, Lainchbury JG, Fisher S, and Yandle TG (2002) Plasma urotensin II in heart failure. Lancet 360:545-546.
17. Russell FD, Meyers D, Galbraith AJ, Bett N, Toth I, Kearns P, and Molenaar P (2003) Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol 285:H1576-H1581.
18. Russell FD, Molenaar P, and O'Brien D (2001) Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol 132:5-9.
19. Samson WK (1998) Proadrenomedullin-derived peptides. Front Neuroendocrinol 19: 100-127.
20. Schlüter H, Jankowski J, Rykl J, Thiemann J, Belgardt S, Zidek W, Wittmann B, and Pohl T (2003) Detection of protease activities with the mass-spectrometry-assisted enzyme-screening (MES) system. Anal Bioanalyt Chem 377:1102-1107.
21. Sugo T, Murakami Y, Shimomura Y, Harada M, Abe M, Ishibashi Y, Kitada C, Miyajima N, Suzuki N, Mori M, et al. (2003) Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun 310:860-868.
22. Takahashi K, Totsune K, Murakami O, and Shibahara S (2001) Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 22:1175-1179.
23. Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, Ito S, Kimura Y, Sasano H, and Murakami O (2001) Role of urotensin II in patients on dialysis. Lancet 358:810-811.
24. Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, Ito S, and Murakami O (2003) Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci 104:1-5.
25. Tzanidis A, Hannan RD, and Krum H (2000) Effect of urotensin II on myocyte hypertrophy and collagen synthesis by myofibroblasts in vitro. Heart Lung Circ 9:A130.
26. Wilkinson IB, Affolter JT, de Haas SL, Pellegrini MP, Boyd J, Winter MJ, Balment RJ, and Webb DJ (2002) High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Cardiovasc Res 53:341-347.
27. Zhang AY, Chen Y-F, Zhang DX, Yi F-X, Qi J, Andrade-Gordon P, de Garavilla L, Li P-L, and Zou A-P (2003) Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. Am J Physiol 285:F792-F798.